CheckPoint is a commercial-stage company focused on developing novel treatments for patients with solid tumor cancers. It reported revenues of $0.04M and a net loss of $27.3M for the nine-month ...
According to the company’s exchange filing, Checkpoint is a Nasdaq-listed commercial-stage company focused on developing novel treatments for patients with solid tumor cancers. “Checkpoint has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback